Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
21 April 2022 | Story Lunga Luthuli | Photo Supplied
Lizandré Mulder
Lizandré Mulder, University of the Free State LLB graduate, does not believe in having a role model, but in striving to be a better version of herself.

Moving from Jansenville – a town outside Uitenhage – to Bloemfontein for her LLB studies, things got off to a shaky start for Lizandré Mulder. New in a ‘big town’, the ‘country girl’ felt out of her element and not used to big-city life. Thanks to her lecturers, the journey to a legal qualification at the University of the Free State (UFS) ended with an average final-year mark of 80% for the Law graduate.

Back in Jansenville, Lizandré’s neighbour nicknamed her ‘klein prokureurtjie (little lawyer)’ as she was growing up, because she had a ‘habit of arguing’, which motivated her to choose law as a career. She says, “arguing with facts earlier, has turned into a passion”. “The competitive side of me always wants to win; I guess that makes me the perfect candidate for a future advocate,” she says.

Managing undergraduate studies, Lizandré – who is also an accomplished athlete – says all she did was study and train. “The only thing I struggled with was my sleeping schedule, as I was constantly tired from hard training, and I studied till the morning hours while I had to wake up again early for morning training.”

The track, field, and cross-country runner has received numerous national medals for the sport and will unfortunately miss the invitation to the annual Excellence Awards in the Faculty of Law, as she will be competing in this year’s South African Athletics Championships in Cape Town on 22 April 2022.

Graduating with the LLB degree, Lizandré plans to finish her master’s degree with a possible topic on the legality of human gene editing in South Africa for the purposes of disease treatment or the prevention thereof.

Lizandré does not believe in having a role model, but to “always try to better myself in every aspect of life. I always believed that true inspiration and motivation come from within”.

After completing her master’s degree, Lizandré will decide on her future career path. She says: “I am still deciding whether I want to remain in Bloemfontein or relocate to Potchefstroom, as the latter has a law firm specialising in medical negligence, a field I would like to specialise in. Besides this, the two cities also boast the best athletics coaches in DB Prinsloo, Head of KovsieSport, and Jean Verster in Potchefstroom has mentored South African award-winning runner, Caster Semenya.

“Somewhere in the future, I definitely also plan on doing my doctoral degree in Law,” says Lizandré.

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept